Connect Biopharma private placement $20.2M; Phase 1 IV rademikibart shows rapid bronchodilation; Phase 3 AD efficacy

Connect Biopharma Holdings Ltd

Raised $20.2M via private placement of 6.13M shares at $3.25; led by Panacea Venture; extends cash runway into H2 2027.
Phase 1 IV rademikibart: rapid FEV1 improvements of 200-400 mL within 15 mins in asthma/COPD, maintained through Day 29.
Phase 3 AD study: 96.6% EASI-75, 87.1% IGA 0/1, 85.3% EASI-90 at week 52; safety comparable to placebo, low conjunctivitis.
Phase 2 Seabreeze STAT data for acute exacerbations expected mid-2026; plans to meet FDA for Phase 3 alignment.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Connect Biopharma Holdings Ltd entered into Purchase Agreement with the purchasers named therein valued at approximately $20.2 million (effective 2026-03-29).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers named therein
Value: approximately $20.2 million
Effective: 2026-03-29

Exact text from the filing

On March 29, 2026, Connect Biopharma Holdings Limited (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of 6,130,000 shares (the “Shares”) of the Company’s ordinary shares, par value $0.000174 per share (the “Ordinary Shares”), at a price of $3.25 per Share

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Connect Biopharma Holdings Ltd filing history →

Source: SEC EDGAR

accession 0001835268-26-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.